© Globe Newswire
18.06.2025
BAVA
LISTED
CPH
Bavarian Nordic Announces Sale of Priority Review Voucher for USD 160 Million
News Preview
COPENHAGEN, Denmark, June 18, 2025 – Bavarian Nordic A/S (OMX: BAVA) announced today that it has entered into an agreement to sell its Priority Review Voucher (PRV) for a total cash consideration of USD 160 million....
Themefolio
Profiler
Peergroup
© EQS Newswire
18.06.2025
FYB
LISTED
XETR
Zeichnung der Unternehmensanleihe 2025/2029 gestartet
News Preview
Pressemitteilung // 18. Juni 2025
Formycon AG: Zeichnung der Unternehmensanleihe 2025/2029 gestartet
Planegg-Martinsried – Die Formycon AG (FWB: FYB, Prime Standard, „Formycon") gibt bekannt, dass der Wertpapierprospekt am 17. Juni durch die luxemburgische Finanzaufsichtsbehörde CSSF gebilligt wurde und die Unternehmensanleihe 2025/2029 (ISIN NO0......
Themefolio
Profiler
Peergroup
© EQS Newswire
18.06.2025
FYB
LISTED
XETR
Subscription period for 2025/2029 corporate bond has started
News Preview
Press Release // June 18, 2025
Formycon AG: Subscription period for 2025/2029 corporate bond has started
Planegg-Martinsried, Germany – Formycon AG (FSE: FYB, Prime Standard, “Formycon”) announces that the securities prospectus for the newly issued corporate bond 2025/2029 (ISIN NO0013586024 / WKN A4DFJH) has been approved by the Luxembourg finan......
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© Globe Newswire
18.06.2025
IBAB
LISTED
EURONEXT
Steri-Tek to boost sterilization capacity of its Texas-based center fivefold with IBA’s X-ray irradiation system
News Preview
Louvain-la-Neuve, Belgium, June 18, 2025 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and electron beam and X-ray solutions for industrial advanced irradiation, announced today it has signed a contract with Steri-Tek, a growing irradiation services provider, to install a fully-integrated Be Wide...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
23.01.2026
© Globe Newswire
17.06.2025
MDGL
LISTED
NASDAQ
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
News Preview
CONSHOHOCKEN, Pa., June 17, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), today announced that it granted equity awards on June 15, 2025 to 36 new non-executive employees as equity inducement a...
Themefolio
Profiler
Peergroup
© EQS Newswire
17.06.2025
GXI
LISTED
XETR
Gerresheimer AG reacts to media reports
News Preview
Gerresheimer AG reacts to media reports
Düsseldorf, June 17, 2025. Gerresheimer AG (ISIN: DE000A0LD6E6) reacts to media reports that KPS Capital Partners has decided against teaming up with Warburg Pincus on a potential public take-over offer for Gerresheimer AG.
KPS Capital Partners has informed Gerresheimer AG upon request that they are still i......
Themefolio
Profiler
Peergroup
© EQS Newswire
17.06.2025
GXI
LISTED
XETR
Gerresheimer AG reagiert auf Medienberichte
News Preview
Gerresheimer AG reagiert auf Medienberichte
Düsseldorf, 17. Juni 2025. Gerresheimer AG (ISIN: DE000A0LD6E6) reagiert auf Medienberichte, wonach KPS Capital Partners sich gegen eine Zusammenarbeit mit Warburg Pincus im Hinblick auf ein mögliches öffentliches Übernahmeangebot für die Gerresheimer AG entschieden habe.
KPS Capital Partners hat der Ge......
Themefolio
Profiler
Peergroup
© Globe Newswire
17.06.2025
GNFT
LISTED
EURONEXT
GENFIT: June 17, 2025 Combined Shareholders Meeting Results
News Preview
Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), June 17, 2025 - GENFIT (Nasdaq and Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today announced the results of the Combined Shareholders Meeting which took place on June 17, 2025...
Themefolio
Profiler
Peergroup
© Globe Newswire
17.06.2025
GMAB
LISTED
CPH
Capital Increase in Genmab as a Result of Employee Warrant Exercise
News Preview
Company Announcement...
Themefolio
Profiler
Peergroup
© BusinessWire
17.06.2025
ERF
LISTED
EURONEXT
Eurofins Scientific SE: Director/PDMR Shareholding
News Preview
Eurofins Scientific SE (EUFI.PA) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below.
This notification is made in accordance with the European Market Abuse Regulation.
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSAC...
Themefolio
Profiler
Peergroup
© EQS Newswire
17.06.2025
DIM
LISTED
EURONEXT
Sartorius Stedim Biotech expands manufacturing and R&D capacities for innovative bioprocess solutions in France
News Preview
Sartorius Stedim Biotech SA
/ Key word(s): Expansion
Sartorius Stedim Biotech expands manufacturing and R&D capacities for innovative bioprocess solutions in France 17-Jun-2025 / 16:00 CET/CEST
Aubagne, France | June 17, 2025Sartorius Stedim Biotech expands manufacturing and R&D capacities for innovative bioprocess so......
Themefolio
Profiler
Peergroup
© PR Newswire
17.06.2025
CU6
LISTED
ASX
Clarity enters a Commercial Manufacturing Agreement for Cu-64 SAR-bisPSMA with SpectronRx
News Preview
Highlights
Clarity has entered into a Commercial Manufacturing Agreement with SpectronRx for 64Cu-SAR-bisPSMA.SpectronRx's facility in Indiana will provide on-demand commercial-scale manufacturing of both copper-64 and 64Cu-SAR-bisPSMA under one roof and enables distribution to all 50 states.SpectronRx will expand current production to up to 400,...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© BusinessWire
17.06.2025
TEM
LISTED
NASDAQ
Tempus to Participate in TD Cowen’s 4th Annual Tools/Dx Revolution Conference
News Preview
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, will participate in TD Cowen's/Securities' 4th Annual Tools/Dx Revolution conference. The event is taking place on June 22 - 25, 2025, in Dana Point, California. Jim Rogers, Chief Financial Officer of Tempus, will join the...
Themefolio
Profiler
Peergroup
© Globe Newswire
17.06.2025
ORY
LISTED
BME
ORYZON to Attend the 2025 Phelan-McDermid Syndrome (PMS) Congress in Barcelona on June 26-29
News Preview
MADRID and CAMBRIDGE, Mass., June 17, 2025 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company and a European leader in epigenetics, announced today that its Chief Scientific Officer, Dr. Jordi Xaus will be attending the 2025 Phelan-McDermid Syndrome Congress in Barcelona on June 26...
Themefolio
Profiler
Peergroup
© Globe Newswire
17.06.2025
SKYE
LISTED
NASDAQ
Skye Bioscience to Present Expanded Preclinical CB1 Antibody Data at the American Diabetes Association’s 85th Scientific Sessions
News Preview
SAN DIEGO, June 17, 2025 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biotechnology company focused on unlocking new therapeutic pathways for obesity and other metabolic health disorders, today announced that it was selected to present new nimacimab data in its expanded preclinical model at the upcoming Amer...
Themefolio
Profiler
Peergroup
© EQS Newswire
17.06.2025
FME
LISTED
XETR
Fresenius Medical Care AG beschließt Aktienrückkaufprogramm mit einem Gesamtvolumen von EUR 1 Milliarde in mehreren Tranchen innerhalb von 2 Jahren
News Preview
Bad Homburg, 17. Juni 2025 - Die Fresenius Medical Care AG („Gesellschaft“) hat beschlossen, ein Aktienrückkaufprogramm mit einem Volumen von EUR 1 Milliarde (ohne Erwerbsnebenkosten) in mehreren Tranchen innerhalb von zwei Jahren ab dem Start des Programms durchzuführen.
Es ist geplant, die Durchführung des Aktienrückkaufprogramms in mehreren Tra......
Themefolio
Profiler
Peergroup
© EQS Newswire
17.06.2025
FME
LISTED
XETR
Fresenius Medical Care AG resolves share buyback program with a total volume of EUR 1 billion in tranches within 2 years
News Preview
Bad Homburg, June 17, 2025 – Fresenius Medical Care AG (“Company”) has decided to conduct a share buyback program with a volume of EUR 1 billion (excluding ancillary costs) in tranches within two years after the start of the program.
The execution of the share buyback program in tranches is planned to commence in the second half of 2025. The share......
Themefolio
Profiler
Peergroup
© EQS Newswire
17.06.2025
FYB
LISTED
XETR
Formycon plant öffentliche Unternehmensanleihe zur Unterstützung der nächsten Wachstumsphase im attraktiven Biosimilar-Markt
News Preview
Pressemitteilung // 17. Juni 2025
Formycon plant öffentliche Unternehmensanleihe zur Unterstützung der nächsten Wachstumsphase im attraktiven Biosimilar-Markt
Unbesicherte Anleihe 2025/2029 hat Zielvolumen von 50 Mio. Euro und ist variabel verzinst
Erlöse unterstützen gezielte Weiterentwicklung des Biosimilar-Produktportfolios und die Umsetzun......
Themefolio
Profiler
Peergroup
© EQS Newswire
17.06.2025
FYB
LISTED
XETR
Formycon plans public corporate bond issuance to support next growth phase within attractive Biosimilar markets
News Preview
Press Release // June 17, 2025
Formycon plans public corporate bond issuance to support next growth phase within attractive Biosimilar markets
Unsecured bond 2025/2029 with a target volume of EUR 50 million and variable interest rate
Proceeds will support the targeted development of biosimilar product portfolio and the execution of the next grow......
Themefolio
Profiler
Peergroup
© EQS Newswire
17.06.2025
FYB
LISTED
XETR
Formycon plant Begebung einer unbesicherten und variabel verzinslichen öffentlich handelbaren Anleihe mit einem Zielvolumen von EUR 50 Mio. zur Unterstützung des weiteren Unternehmenswachstums
News Preview
Veröffentlichung von Insiderinformationen nach Artikel 17 der Verordnung (EU) Nr. 596/2014
NICHT ZUR VERBREITUNG, VERÖFFENTLICHUNG ODER WEITERGABE, DIREKT ODER INDIREKT, IN ODER INNERHALB DER VEREINIGTEN STAATEN VON AMERIKA, KANADA, AUSTRALIEN, JAPAN ODER ANDEREN LÄNDERN, IN DENEN DIE VERBREITUNG ODER VERÖFFENTLICHUNG RECHTSWIDRIG SEIN KÖNNTE. ES ......
Themefolio
Profiler
Peergroup
© EQS Newswire
17.06.2025
FYB
LISTED
XETR
Formycon plans to issue a public senior unsecured floating rate bond with target volume of EUR 50 million to support further company growth
News Preview
Disclosure of Inside Information Pursuant to Article 17 of Regulation (EU) No. 596/2014
NOT FOR DISTRIBUTION, PUBLICATION OR TRANSMISSION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, AUSTRALIA, JAPAN OR ANY OTHER JURISDICTION IN WHICH SUCH DISTRIBUTION OR PUBLICATION MAY BE UNLAWFUL. FURTHER RESTRICTIONS APPLY. PLEASE ......
Themefolio
Profiler
Peergroup
© Globe Newswire
17.06.2025
ORNBV
LISTED
HEL
Orion and Glykos announce the extension of their research collaboration and licensing agreement for the development of next-generation ADCs
News Preview
ORION CORPORATION PRESS RELEASE 17 JUNE 2025 at 9.00 EEST ...
Themefolio
Profiler
Peergroup
© BusinessWire
17.06.2025
TEM
LISTED
NASDAQ
TEMPUS AI SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Tempus AI, Inc. - TEM
News Preview
Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until August 12, 2025 to file lead plaintiff applications in a securities class action lawsuit against Tempus AI, Inc. (NasdaqGS: TEM), if they purchased the Company’s shares between August 6, 2024 and May...
Themefolio
Profiler
Peergroup
© ACCESS Newswire
17.06.2025
CLBX
LISTED
AIMX
Angle PLC - EACR 2025: Data Demonstrating DNA Dual Analysis
News Preview
ANGLE presents new data at EACR 2025 DEMONSTRATING DNA DUAL ANALYSIS FOR COMPREHENSIVE LIQUID BIOPSY PROFILINGPoster highlights ANGLE's combined CTC-DNA and ctDNA analysis revealing tumour heterogeneity in lung cancer patients GUILDFORD, SURREY / ACCESS Newswire / June 17, 2025 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy compa...
Themefolio
Profiler
Peergroup
© BusinessWire
16.06.2025
TEM
LISTED
NASDAQ
TEM Investors Have Opportunity to Lead Tempus AI, Inc. Securities Fraud Lawsuit with the Schall Law Firm
News Preview
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Tempus AI, Inc. (“Tempus” or “the Company”) (NASDAQ: TEM) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Investor...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.06.2025
GMAB
LISTED
CPH
Transactions in Connection with Share Buy-back Program
News Preview
Company Announcement...
Themefolio
Profiler
Peergroup
© PR Newswire
16.06.2025
RAY B
LISTED
STO
RayStation used for pioneering clinical milestone at Helsinki University Hospital - first treatment with accelerator-based BNCT in Europe
News Preview
STOCKHOLM, June 16, 2025 /PRNewswire/ -- RaySearch Laboratories AB (publ) is pleased to announce that RayStation®*, its advanced treatment planning system, was used in the first European clinical treatments with Neutron Therapeutics' accelerator-based boron neutron capture therapy (BNCT), carried out on a patient at Helsinki University Hospital i...
Themefolio
Profiler
Peergroup
© PR Newswire
16.06.2025
SECT_B
LISTED
STO
Canadian hospital system leverages Sectra's AI service to enhance patient care and workflow efficiency
News Preview
LINKÖPING, Sweden and MISSISSAUGA, ON, June 16, 2025 /PRNewswire/ -- William Osler Health System (Osler) in Canada leverages AI through the international medical imaging IT and cybersecurity company Sectra's (STO: SECT B) AI service, Sectra Amplifier Service. This collaboration enables Osler to seamlessly integrate selected AI applications into t...
Themefolio
Profiler
Peergroup
© Globe Newswire
15.06.2025
GMAB
LISTED
CPH
Genmab Announces Epcoritamab Investigational Combination Therapy Demonstrates High Response Rates in Patients with Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) Eligible for Autologous Stem Cell Transplantation (ASCT)
News Preview
Media ReleaseCOPENHAGEN, Denmark; June 15, 2025...
Themefolio
Profiler
Peergroup
© PR Newswire
13.06.2025
CU6
LISTED
ASX
SABRE topline results: Cu-64 SAR-Bombesin is effective in detecting prostate cancer recurrence in patients with negative SOC imaging
News Preview
Highlights
Topline data from Clarity's diagnostic Phase II trial, SABRE, showed that 64Cu-SAR-Bombesin was safe, well tolerated and effective at detecting prostate cancer in patients with biochemical recurrence (BCR) who are negative or equivocal on standard-of-care (SOC) scans, including prostate-specific membrane antigen (PSMA) Positron Emissio...
Themefolio
Profiler
Peergroup
© BusinessWire
13.06.2025
ERF
LISTED
EURONEXT
Eurofins Scientific SE: Director/PDMR Shareholding
News Preview
Eurofins Scientific SE (EUFI.PA) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below.
This notification is made in accordance with the European Market Abuse Regulation.
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS...
Themefolio
Profiler
Peergroup
© BusinessWire
13.06.2025
HELP
LISTED
NASDAQ
Cybin Provides Corporate Update and Highlights Positive Regulatory Signals for Psychedelic Therapeutics
News Preview
Cybin Inc. (NYSE American:CYBN) (Cboe Canada CA:CYBN) (“Cybin” or the “Company”), a clinical-stage breakthrough neuropsychiatry company committed to revolutionizing mental healthcare by developing new and innovative next-generation treatment options, today provided a corporate update.
“It is especially gratifying that at a time when we are advan...
Themefolio
Profiler
Peergroup
© BusinessWire
13.06.2025
ZLAB
LISTED
NASDAQ
Zai Lab Presents New Preclinical Data for ZL-1503, an IL-13/IL-31R Bispecific Antibody for the Treatment of Atopic Dermatitis, at EAACI Congress 2025
News Preview
Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced new data from its preclinical study of ZL-1503, the Company’s promising IL-13/IL-31R bispecific antibody, demonstrating its ability to simultaneously suppress the inflammatory and pruritogenic (itch-causing) pathways in atopic dermatitis (AD). The findings, featured during a poster present...
Themefolio
Profiler
Peergroup
© PR Newswire
13.06.2025
BIOA B
LISTED
STO
BioArctic to initiate next cohorts in exidavnemab Phase 2a study after positive safety review
News Preview
STOCKHOLM, June 13, 2025 /PRNewswire/ -- BioArctic AB (publ) (NASDAQ Stockholm: BIOA B) announced today that the interim safety review of the clinical Phase 2a study EXIST showed exidavnemab to be safe and well-tolerated, whereby the second dose cohorts will now be initiated. The EXIST study evaluates exidavnemab, a drug candidate being developed...
Themefolio
Profiler
Peergroup
© PR Newswire
13.06.2025
BIOA B
LISTED
STO
BioArctic to initiate next cohorts in exidavnemab Phase 2a study after positive safety review
News Preview
STOCKHOLM, June 13, 2025 /PRNewswire/ -- BioArctic AB (publ) (NASDAQ Stockholm: BIOA B) announced today that the interim safety review of the clinical Phase 2a study EXIST showed exidavnemab to be safe and well-tolerated, whereby the second dose cohorts will now be initiated. The EXIST study evaluates exidavnemab, a drug candidate being developed...
Themefolio
Profiler
Peergroup
© Globe Newswire
12.06.2025
DBV
LISTED
EURONEXT
DBV Technologies to Participate in Upcoming EAACI Congress 2025
News Preview
Châtillon, France, June 12, 2025...
Themefolio
Profiler
Peergroup
© Globe Newswire
12.06.2025
GLPG
LISTED
EURONEXT
Galapagos to Present New ATALANTA-1 CAR-T Data at EHA 2025, Highlighting Low Toxicity and Rapid, Decentralized Delivery of Fresh, Early-Memory-Enriched GLPG5101 in R/R NHL
News Preview
Data reported from the ongoing ATALANTA-1 Phase 1/2 study in a heavily pretreated relapsed refractory non-Hodgkin’s Lymphoma (R/R NHL) patient population demonstrate low rates of high-grade toxicities...
Themefolio
Profiler
Peergroup
© ActuNews
12.06.2025
OXUR
LISTED
EURONEXT
Oxurion ontvangt aangepaste transparantiekennisgevingen van Atlas Special Opportunities II LLC
News Preview
Leuven, BELGIË – 12 juni 2025 – 18u00 CET Oxurion NV (Euronext Brussel: OXUR), een biofarmaceutisch bedrijf met hoofdkantoor in Leuven, België, heeft vandaag aangekondigd dat het, in overeenstemming met de Belgische transparantiewetgeving1, de volgende transparantiekennisgevingen heeft ontvangen:
Oxurion ontving een transparan...
Themefolio
Profiler
Peergroup
© ActuNews
12.06.2025
OXUR
LISTED
EURONEXT
Oxurion Receives Amended Transparency Notification from Atlas Special Opportunities II LLC
News Preview
Leuven, BELGIUM – June 12, 2025 – 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today announced that, pursuant to Belgian Transparency legislation1 it has received a transparency notification as follows:
Oxurion received a transparency notification on June 11, 2025, from Atlas...
Themefolio
Profiler
Peergroup
© Globe Newswire
12.06.2025
GMAB
LISTED
CPH
Grant of Restricted Stock Units and Warrants to Employees in Genmab
News Preview
Company Announcement...
Themefolio
Profiler
Peergroup
© BusinessWire
12.06.2025
TEM
LISTED
NASDAQ
Tempus Announces Collaboration with Northwestern University’s Abrams Research Center on Neurogenomics to Leverage AI for Alzheimer’s Disease Research
News Preview
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced a collaboration with The Abrams Research Center on Neurogenomics at Northwestern University Feinberg School of Medicine. This multi-year collaboration aims to harness AI for rapid discovery and innovation i...
Themefolio
Profiler
Peergroup
© PR Newswire
12.06.2025
CYRX
LISTED
NASDAQ
Cryoport Completes CRYOPDP Divestiture and Commences Strategic Partnership with DHL Group
News Preview
NASHVILLE, Tenn., June 12, 2025 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a leader in temperature-controlled supply chain solutions for the Life Sciences, with a focus on regenerative medicine, today announced the completion of the previously disclosed divestiture of its specialty courier business, CRYOPDP, to D...
Themefolio
Profiler
Peergroup
© BusinessWire
12.06.2025
SLP
LISTED
NASDAQ
Simulations Plus to Participate in the Citizens Medical Devices and Healthcare Services Forum
News Preview
Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”, “SLP”), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry, today announced that Shawn O’Connor, Chief Executive Officer, will be participating in the Citizens Medical Devices...
Themefolio
Profiler
Peergroup
© BusinessWire
12.06.2025
HELP
LISTED
NASDAQ
Cybin to Participate in the H.C. Wainwright 6th Annual Neuro Perspectives Conference
News Preview
Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) (“Cybin” or the “Company”), a clinical-stage breakthrough neuropsychiatry company committed to revolutionizing mental healthcare by developing new and innovative next-generation treatment options, is pleased to announce that Doug Drysdale, Cybin’s Chief Executive Officer, will participate in a virtual...
Themefolio
Profiler
Peergroup
© Globe Newswire
12.06.2025
AMRX
LISTED
NASDAQ
Amneal Receives U.S. FDA Approval for Prednisolone Acetate Ophthalmic Suspension
News Preview
BRIDGEWATER, N.J., June 12, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (“Amneal” or the “Company”) today announced the U.S. Food and Drug Administration (FDA) approval of prednisolone acetate ophthalmic suspension, 1% sterile which references Pred Forte®. Pred Forte and its design are trademarks of Allergan, Inc., an AbbVie company. La...
Themefolio
Profiler
Peergroup
© PR Newswire
12.06.2025
SOBI
LISTED
STO
Sobi share new clinical data across multiple hematologic diseases at EHA 2025
News Preview
STOCKHOLM, June 12, 2025 /PRNewswire/ -- Sobi® (STO: SOBI) will present data at the 30th EHA (European Haematology Association) hybrid congress, in Milan, Italy (12-15 June). The congress will feature the latest advances in the treatment of diffuse large B-cell lymphoma (DLBCL), immune thrombocytopenia (ITP), myelofibrosis, paroxysmal nocturnal h...
Themefolio
Profiler
Peergroup
© Globe Newswire
12.06.2025
NSIS B
LISTED
CPH
Major shareholder announcement
News Preview
Pursuant to Section 30 of the Danish Capital Markets Act, Novonesis hereby announces that BlackRock, Inc. has notified Novonesis of the following status relating to the position of share capital attached to shares and share capital through financial instruments....
Themefolio
Profiler
Peergroup
© ActuNews
12.06.2025
OXUR
LISTED
EURONEXT
Oxurion boekt vooruitgang met de voorgenomen overname van Axiodis
News Preview
Leuven, BELGIË – 12 juni 2025 – 8u30 CET – Oxurion NV (Euronext Brussel: OXUR), een biofarmaceutisch bedrijf met hoofdkantoor in Leuven, kondigt aan dat de opschortende voorwaarde met betrekking tot het voorafgaand informatie- en raadplegingsrecht van de werknemers, overeenkomstig artikel L.23-10-1 van het Franse Wetboek van...
Themefolio
Profiler
Peergroup
© ActuNews
12.06.2025
OXUR
LISTED
EURONEXT
Oxurion moves forward with the planned acquisition of Axiodis
News Preview
Leuven, BELGIUM – June 12, 2025 at 8:30 AM CET, Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company based in Leuven, announces the lifting of the condition precedent relating to the completion of the employee information process as per Article L.23-10-1 of the French Commercial Code. This milestone represents a key step towards...
Themefolio
Profiler
Peergroup
© ActuNews
12.06.2025
OXUR
LISTED
EURONEXT
Oxurion avance dans l'acquisition projetée d'Axiodis
News Preview
Louvain, BELGIQUE – 12 juin 2025 – 8h30, Oxurion NV (Euronext Bruxelles : OXUR), société biopharmaceutique basée à Louvain, annonce la levée de la condition suspensive relative au droit d'information préalable des salariés, conformément à l'article L.23-10-1 du Code...
Themefolio
Profiler
Peergroup
© Globe Newswire
12.06.2025
CLARI
LISTED
EURONEXT
Clariane completes its plan to strengthen its financial structure with the disposal of its Petits-fils home care services network
News Preview
...
Themefolio
Profiler
Peergroup
© Globe Newswire
12.06.2025
BAVA
LISTED
CPH
Bavarian Nordic Initiates Phase 3 Study of Chikungunya Vaccine in Children
News Preview
COPENHAGEN, Denmark, June 12, 2025 – Bavarian Nordic A/S (OMX: BAVA) announced today the initiation of a Phase 3 clinical study of its single-dose, virus-like particle (VLP) chikungunya vaccine, CHIKV VLP in children 2 to 11 years of age....
Themefolio
Profiler
Peergroup
© BusinessWire
11.06.2025
SLP
LISTED
NASDAQ
Simulations Plus Announces Preliminary Third Quarter Fiscal 2025 Revenue
News Preview
Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus” or the “Company”), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry, today announced preliminary revenue for its third fiscal quarter and updated its full year 2025 revenue gu...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.06.2025
DBV
LISTED
EURONEXT
DBV Technologies Announces the Voting Results of its 2025 Combined General Meeting
News Preview
Châtillon, France, June 11, 2025...
Themefolio
Profiler
Peergroup
© ActuNews
11.06.2025
OXUR
LISTED
EURONEXT
Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC
News Preview
Leuven, BELGIUM – June 11, 2025 – 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today announced that, pursuant to Belgian Transparency legislation1 it has received transparency notifications as follows:
Oxurion received a transparency notification on June 9, 2025, from Atlas Sp...
Themefolio
Profiler
Peergroup
© ActuNews
11.06.2025
OXUR
LISTED
EURONEXT
Oxurion ontvangt transparantiekennisgevingen van Atlas Special Opportunities II LLC
News Preview
Leuven, BELGIË – 11 juni 2025 – 18u00 CET Oxurion NV (Euronext Brussel: OXUR), een biofarmaceutisch bedrijf met hoofdkantoor in Leuven, België, heeft vandaag aangekondigd dat het, in overeenstemming met de Belgische transparantiewetgeving1, de volgende transparantiekennisgevingen heeft ontvangen:
Oxurion ontving een transparan...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.06.2025
OSE
LISTED
EURONEXT
ADJOURNMENT OF THE GENERAL MEETING INITALLY CONVENED ON JUNE 25, 2025
News Preview
ADJOURNMENT OF THE GENERAL MEETING INITALLY CONVENED ON JUNE 25, 2025...
Themefolio
Profiler
Peergroup
© BusinessWire
11.06.2025
HELP
LISTED
NASDAQ
Cybin to Participate in the 2025 Psychedelic Science Conference
News Preview
Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) (“Cybin” or the “Company”), a clinical-stage breakthrough neuropsychiatry company committed to revolutionizing mental healthcare by developing new and innovative next-generation treatment options, is pleased to announce that Doug Drysdale, Cybin’s Chief Executive Officer, will be speaking at the Psych...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.06.2025
OXB
LISTED
LSE
AGM Update
News Preview
Oxford, UK – 11 June 2025: OXB (LSE: OXB) (“the Company”), a global quality and innovation-led cell and gene therapy CDMO, provides an update to coincide with its Annual General Meeting being held at 3pm BST today at Windrush Court, Oxford, UK....
Themefolio
Profiler
Peergroup
© Globe Newswire
11.06.2025
TIL
LISTED
NASDAQ
Instil Bio Names John Maraganore, Ph.D., to Board Role Supporting the Advancement of PD-L1xVEGF Bispecific Antibody Program
News Preview
DALLAS, June 11, 2025 (GLOBE NEWSWIRE) -- Instil Bio, Inc. (“Instil”) (NASDAQ: TIL), a clinical-stage biopharmaceutical company focused on developing a pipeline of novel therapies, today announced the addition of John Maraganore, Ph.D., to the Board of Directors of Axion Bio, Inc., Instil’s wholly-owned subsidiary dedicated to the development of...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
